AirICU belongs to the feellife group, a healthcare company centered around treating the upper and lower respiratory tracts of the human body. With the vision of "The Third Way of Dosing" and the technology core of "AiMesh ®" polymer nebulizer, feellife owns more than 250+ international invention patents and certificates, taking the leading position in the field of nebulized drug delivery, and the clinical nebulization equipment for hospital intensive care represented by "AirICU" has already benefited millions of patients in more than 40 countries and regions.
AirICU has been recognized by the medical and product design industry for its technology over the years.
We take pride in responding to your questions and comments
中国大陆
简体中文
United Kingdom
English
